|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
RCUS
|
Arcus Biosciences, Inc.
|
US
|
NYSE
|
|
SABS
|
SAB Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|
|
STAB
|
Statera Biopharma, Inc.
|
US
|
NASDAQ
|
|
SURF
|
Surface Oncology, Inc.
|
US
|
NASDAQ
|
|
XLO
|
Xilio Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IMU
|
Imugene Limited
|
AU
|
ASX
|
|
ADXS
|
Advaxis Inc
|
US
|
OTC
|
|
AGYTF
|
Allergy Therapeutics
|
US
|
OTC
|
|
CMVLF
|
Cellectis Romainvil
|
US
|
OTC
|
|
HMDCF
|
Hutchison China Ltd
|
US
|
OTC
|
|
IMUC
|
Immunocellular Thera
|
US
|
OTC
|
|
IUGNF
|
IMUGENE LTD
|
US
|
OTC
|
|
JWCTF
|
Jw Cayman Therapeutics CO Ltd
|
US
|
OTC
|
|
MDGEF
|
Medigene Ag
|
US
|
OTC
|
|
VXLLF
|
Vaxil Bio Ltd.
|
US
|
OTC
|
|
QPT
|
Quest Pharmatech Inc.
|
CA
|
TSXV
|
|
VXL
|
Vaxil Bio Ltd.
|
CA
|
TSXV
|
|
SCLP
|
Scancell Holdings Plc
|
UK
|
LSE
|